Home LiteratureArticle Details
PMID: 3546145 Published · ppublish English Comparative Study Journal Article

The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms.

Infection ·Vol. 14 ·No. 6 ·1986-00-00 ·Pages 294-8

Vanhoof R, Hubrechts JM, Roebben E, Nyssen HJ, Nulens E, Leger J, De Schepper N

Abstract

In this study, we compared the activity of pefloxacin, enoxacin and ciprofloxacin against 269 enteropathogenic strains (Campylobacter jejuni, enteropathogenic Escherichia coli, Salmonella typhi, Shigella spp., Vibrio cholerae and Yersinia enterocolitica) with that of rosoxacin, flumequin, nifuroxazide, erythromycin, chloramphenicol, ampicillin, cefotaxime, tetracycline, amikacin, netilmicin, sulfamethoxazole, trimethoprim and co-trimoxazole. Pefloxacin, enoxacin and ciprofloxacin were always among the most active compounds. Furthermore, resistant strains or strains with elevated MIC values were not found. The MIC90 value for these three compounds was less than or equal to 0.25 mg/l, except for C. jejuni where it was 0.3 mg/l and 1.4 mg/l for pefloxacin and enoxacin, respectively.

MeSH Terms
Animals Anti-Bacterial Agents/pharmacology Campylobacter fetus/drug effects Ciprofloxacin/pharmacology Enoxacin Escherichia coli/drug effects Humans Microbial Sensitivity Tests Naphthyridines/pharmacology Norfloxacin/analogs & derivatives,pharmacology Pefloxacin Salmonella typhi/drug effects Shigella/drug effects Vibrio cholerae/drug effects Yersinia enterocolitica/drug effects
Chemicals
Anti-Bacterial Agents Naphthyridines Pefloxacin Enoxacin Ciprofloxacin Norfloxacin
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Vanhoof R
Hubrechts J M
Roebben E
Nyssen H J
Nulens E
Leger J
De Schepper N
References (20)
20 references, click to expand
  1. Yersinia enterocolitica: in vitro antimicrobial susceptibility.
    Antimicrob Agents Chemother. 1978 May;13(5):888-90 PMID: 666308
  2. Nalidixic-acid-resistant Shigella dysenteriae I.
    Lancet. 1985 Mar 30;1(8431):763 PMID: 2858035
  3. Antimicrobial susceptibility of Vibrio cholerae from Zaire and Rwanda.
    Lancet. 1979 Oct 20;2(8147):849 PMID: 90940
  4. In-vitro susceptibility of salmonellae to antimicrobial agents.
    J Antimicrob Chemother. 1984 Jun;13(6):559-65 PMID: 6540771
  5. In vitro susceptibilities of 126 clinical isolates of Yersinia enterocolitica to 21 beta-lactam antibiotics.
    Antimicrob Agents Chemother. 1985 May;27(5):806-11 PMID: 2990327
  6. Bacteriostatic and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp. jejuni.
    Antimicrob Agents Chemother. 1980 Jul;18(1):118-21 PMID: 7416738
  7. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.
    Antimicrob Agents Chemother. 1985 Oct;28(4):581-6 PMID: 3000292
  8. The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.
    Antimicrob Agents Chemother. 1985 Nov;28(5):716-21 PMID: 2936302
  9. Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents.
    Antimicrob Agents Chemother. 1978 Oct;14(4):553-6 PMID: 718153
  10. In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim.
    Antimicrob Agents Chemother. 1983 Nov;24(5):754-63 PMID: 6229216
  11. In vitro susceptibility of pathogenic Vibrio species to norfloxacin and six other antimicrobial agents.
    Antimicrob Agents Chemother. 1985 Sep;28(3):442-5 PMID: 4073866
  12. Antibiotic resistance of Salmonella in Europe and the United States.
    Rev Infect Dis. 1981 Nov-Dec;3(6):1105-26 PMID: 7043703
  13. Drug resistance in Shigella dysenteriae, S flexneri and S boydii in England and Wales: increasing incidence of resistance to trimethoprim.
    Br Med J (Clin Res Ed). 1984 Mar 10;288(6419):784-6 PMID: 6423079
  14. In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens.
    Antimicrob Agents Chemother. 1983 Jan;23(1):86-90 PMID: 6219622
  15. Treatment of Salmonella typhi carrier state with ciprofloxacin.
    Lancet. 1985 May 4;1(8436):1047 PMID: 2859498
  16. Activity of bicozamycin (CGP 3543/E) on different enteropathogenic micro-organisms: comparison with other antimicrobial agents.
    J Antimicrob Chemother. 1982 Oct;10 (4):343-6 PMID: 7142080
  17. Susceptibility of shigellae to mecillinam, nalidixic acid, trimethoprim, and five other antimicrobial agents.
    Antimicrob Agents Chemother. 1981 Feb;19(2):271-3 PMID: 6289727
  18. Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens.
    Antimicrob Agents Chemother. 1985 Mar;27(3):388-92 PMID: 3158276
  19. Susceptibility pattern of Campylobacter jejuni from human and animal origins to different antimicrobial agents.
    Antimicrob Agents Chemother. 1982 Jun;21(6):990-2 PMID: 7114842
  20. Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens.
    Antimicrob Agents Chemother. 1984 Apr;25(4):504-6 PMID: 6732220
Article Info
Journal
Infection
Abbr.
Infection
ISSN
0300-8126
Published
1986-00-00
Pages
294-8
Language
English
Region
Germany
NLM ID
0365307
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]